Reilly Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | $18K | Hold |
47
| – | – | ﹤0.01% | 581 |
|
2021
Q3 | $19K | Hold |
47
| – | – | ﹤0.01% | 533 |
|
2021
Q2 | $17K | Hold |
47
| – | – | ﹤0.01% | 576 |
|
2021
Q1 | $14K | Hold |
47
| – | – | ﹤0.01% | 616 |
|
2020
Q4 | $12K | Hold |
47
| – | – | ﹤0.01% | 586 |
|
2020
Q3 | $11K | Hold |
47
| – | – | ﹤0.01% | 548 |
|
2020
Q2 | $8K | Hold |
47
| – | – | ﹤0.01% | 623 |
|
2020
Q1 | $6K | Hold |
47
| – | – | ﹤0.01% | 642 |
|
2019
Q4 | $7K | Hold |
47
| – | – | ﹤0.01% | 681 |
|
2019
Q3 | $6K | Hold |
47
| – | – | ﹤0.01% | 709 |
|
2019
Q2 | $7K | Hold |
47
| – | – | ﹤0.01% | 721 |
|
2019
Q1 | $7K | Buy |
+47
| New | +$7K | ﹤0.01% | 742 |
|
2016
Q3 | – | Sell |
-34
| Closed | -$3K | – | 844 |
|
2016
Q2 | $3K | Buy |
+34
| New | +$3K | ﹤0.01% | 673 |
|